| Community-acquired pneumonia S Aliberti, CSD Cruz, F Amati, G Sotgiu, MI Restrepo The Lancet 398 (10303), 906-919, 2021 | 119 | 2021 |
| Neutrophil elastase in bronchiectasis A Gramegna, F Amati, L Terranova, G Sotgiu, P Tarsia, D Miglietta, ... Respiratory research 18, 1-13, 2017 | 107 | 2017 |
| Early phases of COVID-19 are characterized by a reduction in lymphocyte populations and the presence of atypical monocytes A Lombardi, E Trombetta, A Cattaneo, V Castelli, E Palomba, M Tirone, ... Frontiers in immunology 11, 560330, 2020 | 68 | 2020 |
| The biology of pulmonary exacerbations in bronchiectasis F Amati, E Simonetta, A Gramegna, P Tarsia, M Contarini, F Blasi, ... European Respiratory Review 28 (154), 2019 | 66 | 2019 |
| Prognostic parameters of in‐hospital mortality in COVID‐19 patients—An Italian experience M Ruscica, C Macchi, S Iodice, G Tersalvi, I Rota, S Ghidini, L Terranova, ... European journal of clinical investigation 51 (9), e13629, 2021 | 34 | 2021 |
| Aspiration risk factors, microbiology, and empiric antibiotics for patients hospitalized with community-acquired pneumonia J Marin-Corral, S Pascual-Guardia, F Amati, S Aliberti, JR Masclans, ... Chest 159 (1), 58-72, 2021 | 31 | 2021 |
| Overweight and obesity in adults with cystic fibrosis: an Italian multicenter cohort study A Gramegna, S Aliberti, M Contarini, D Savi, G Sotgiu, F Majo, L Saderi, ... Journal of Cystic Fibrosis 21 (1), 111-114, 2022 | 30 | 2022 |
| T2-High Endotype and Response to Biological Treatments in Patients with Bronchiectasis M Oriano, A Gramegna, F Amati, A D’Adda, M Gaffuri, M Contoli, F Bindo, ... Biomedicines 9 (7), 772, 2021 | 29 | 2021 |
| SARS-CoV-2 vaccines: A critical perspective through efficacy data and barriers to herd immunity F Blasi, A Gramegna, G Sotgiu, L Saderi, A Voza, S Aliberti, F Amati Respiratory medicine 180, 106355, 2021 | 28 | 2021 |
| COVID‐19 in lung transplant recipients: a case series from Milan, Italy LC Morlacchi, V Rossetti, L Gigli, F Amati, L Rosso, S Aliberti, M Nosotti, ... Transplant Infectious Disease 22 (6), e13356, 2020 | 27 | 2020 |
| Protease–Antiprotease imbalance in bronchiectasis M Oriano, F Amati, A Gramegna, A De Soyza, M Mantero, O Sibila, ... International journal of molecular sciences 22 (11), 5996, 2021 | 24 | 2021 |
| Microbial dysregulation of the gut-lung axis in bronchiectasis JK Narayana, S Aliberti, M Mac Aogáin, TK Jaggi, NABM Ali, FX Ivan, ... American Journal of Respiratory and Critical Care Medicine 207 (7), 908-920, 2023 | 23 | 2023 |
| COVID-19 multidisciplinary high dependency unit: the Milan model S Aliberti, F Amati, M Pappalettera, M Di Pasquale, A D’Adda, M Mantero, ... Respiratory Research 21, 1-12, 2020 | 22 | 2020 |
| Lung microbiome in idiopathic pulmonary fibrosis and other interstitial lung diseases F Amati, A Stainer, M Mantero, A Gramegna, E Simonetta, G Suigo, ... International journal of molecular sciences 23 (2), 977, 2022 | 20 | 2022 |
| Predictors of helmet CPAP failure in COVID-19 pneumonia: a prospective, multicenter, and observational cohort study P Santus, S Pini, F Amati, M Saad, M Gatti, M Mondoni, F Tursi, M Rizzi, ... Canadian Respiratory Journal 2022, 2022 | 16 | 2022 |
| Comparison of different conditions for DNA extraction in sputum-a pilot study M Oriano, L Terranova, A Teri, S Sottotetti, L Ruggiero, C Tafuro, ... Multidisciplinary Respiratory Medicine 14, 1-8, 2019 | 16 | 2019 |
| Prognostic value of copeptin and mid‐regional proadrenomedullin in COVID‐19‐hospitalized patients R Indirli, A Bandera, L Valenti, F Ceriotti, A Di Modugno, M Tettamanti, ... European journal of clinical investigation 52 (5), e13753, 2022 | 15 | 2022 |
| Investigating the etiology of bronchiectasis: you do not find what you do not look for F Amati, E Franceschi, A Gramegna, JD Chalmers, S Aliberti Respiration 93 (3), 228-229, 2017 | 15 | 2017 |
| Onset of systemic arterial hypertension after initiation of elexacaftor/tezacaftor/ivacaftor in adults with cystic fibrosis: A case series A Gramegna, C De Petro, G Leonardi, M Contarini, F Amati, R Meazza, ... Journal of Cystic Fibrosis 21 (5), 885-887, 2022 | 14 | 2022 |
| Efficacy of pirfenidone and nintedanib in interstitial lung diseases other than idiopathic pulmonary fibrosis: a systematic review F Amati, A Stainer, V Polelli, M Mantero, A Gramegna, F Blasi, S Aliberti International Journal of Molecular Sciences 24 (9), 7849, 2023 | 12 | 2023 |
